Back to dashboard
MedicaidCoverageMedium impact

Newsletter Vol. 5, No. 01

New Jersey Medicaid·NJ·Prior Authorization
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

New Jersey Medicaid will only cover brand-name drugs when medically necessary and the prescriber writes 'Brand Medically Necessary' in their own handwriting on each prescription. The state is cracking down on unnecessary brand drug prescribing to control costs and encourage generic alternatives.

Action Required

Action needed
Immediately: Notify all providers that for New Jersey Medicaid patients requiring brand-name drugs, they must handwrite 'Brand Medically Necessary' on each prescription when generics are available but medically inappropriate. Update prescription pads and EMR alerts for NJ Medicaid patients. Educate providers to carefully consider generic alternatives except when brand therapy is truly medically necessary to avoid claim denials.